Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-11

FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s supplemental application for omeprazole sodium bicarbonate (ANDA 207476), confirming its marketing approval in the United Stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OMEPRAZOLE/SODIUM BICARBONATE (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE SODIUM BICARBONATE (OMEPRAZOLE SODIUM BICARBONATE)